ClinicalTrials.Veeva

Menu

DM1 Heart Registry - DM1 Respiratory Registry (DM1-Heart-R)

I

Institut de Myologie, France

Status

Completed

Conditions

Myotonic Dystrophy

Study type

Observational

Funder types

Other

Identifiers

NCT01136330
AFM-13286

Details and patient eligibility

About

Myotonic dystrophy type 1 (DM1) is the most frequent neuromuscular disease in adults. DM1 patients have an impaired prognosis (mean age of death <60 years) due to cardiac and respiratory complications.

Our primary objective was to identify cardiac and respiratory prognostic factors in DM1.

Full description

  1. Patients with genetically proven DM1 who were admitted in Pitié Salpêtrière Hospital from 2000 and 2010 will be identified. These patients systematically underwent neurological, cardiac and respiratory investigations.
  2. Baseline medical and genetic information will be entered in a dedicated database, including cardiac and respiratory investigations.
  3. The occurence of severe cardiac and respiratory adverse events will also be collected.
  4. Statistical analysis will be performed to look for correlations between baseline patient characteristics and cardiac or respiratory adverse events during follow up.

Enrollment

914 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • DM1 mutation (>50 CTG repeats)
  • Age > 18 years

Exclusion criteria

  • Patient refusal

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems